NEW YORK, Sept 22 (Reuters) – Pfizer CEO Albert Bourla and Meta Platforms chief Mark Zuckerberg are the latest corporate leaders to confirm plans to attend US President Donald Trump’s state dinner at the White House on Thursday for Chinese President Xi Jinping, according to sources familiar with the
By Pushkala Aripaka LONDON, Sept 22 (Reuters) – European drugmakers called for beefed-up government spending on medicines, faster trials and IP protections as they sounded warnings on Tuesday that the continent’s pharmaceutical industry risks losing out to the United States and China. Cash-strapped
BEIJING (AP) — China said Tuesday that it is now requiring permits for exports to the United States, Mexico and Canada of two additional chemicals that can be used to make illegal drugs, expanding controls on shipments to the three countries. The Commerce Ministry and other authorities jointly annou
By Christy Santhosh Sept 22 (Reuters) – Amgen said on Tuesday its experimental drug to treat an autoimmune disease that attacks the body’s moisture-producing glands met the main goal of reducing disease activity in a late-stage trial, sending its shares up 4% in morning trading. Here are some detail
Sept 22 (Reuters) – Otsuka Pharmaceutical and Ionis Pharmaceuticals said on Tuesday their experimental drug met the main goal of a late-stage study in patients with a rare inherited form of amyotrophic lateral sclerosis, or ALS. Here are more details: • Otsuka’s ulefnersen improved function and surv
Sept 22 (Reuters) – Novo Nordisk and UNICEF have expanded their partnership to help prevent childhood overweight and obesity, the Danish drugmaker said on Tuesday. The expansion follows UNICEF’s 2025 Child Nutrition Report that found childhood obesity had overtaken underweight for the first time on
By Siddhi Mahatole Sept 22 (Reuters) – Celldex Therapeutics said on Tuesday its experimental drug significantly reduced disease activity in two late-stage trials of patients with a chronic skin condition, clearing a key hurdle toward a U.S. regulatory filing. Shares of the New Jersey-based company f
Sept 22 (Reuters) – Swiss drugmaker Roche said on Tuesday its experimental dual-acting obesity drug helped overweight or obese patients with type 2 diabetes lower blood sugar levels and lose an average 15.5% of their body weight in a mid-stage trial. Roche is racing alongside large drugmakers, inclu
At least six major hospitals have agreed to refuse gender-affirming hormones and surgery for transgender young people and agreed instead to make payments to the federal government for patients who want to reverse gender transitions, according to deals with the Department of Justice. The most recent
Sept 22 (Reuters) – Viking Therapeutics said patients shifted to a less frequent dosing regimen of its experimental obesity treatment showed superior weight loss maintenance to those on placebo, in a study, sending its shares up 40% before the bell. The company said on Tuesday that patients who swit
BEIJING, Sept 22 (Reuters) – China added two chemicals on Tuesday to its export control list for drug precursor chemicals, requiring permits for exports to the US, Mexico and Canada, the commerce ministry said in a statement. The change came ahead of this week’s summit of the Chinese and American le
SOKOTO, Nigeria (AP) — Ibrahim Dalhatu was just 3 years old when he contracted noma, a severe disease that disfigures the face and kills most of the children it infects. He had his first facial reconstructive surgery in 2021 at the Noma Children Hospital in Nigeria’s Sokoto state. Since then, Ibrahi
KATHMANDU, Nepal (AP) — The foreign aid landscape has changed dramatically since U.S. President Donald Trump’s administration dissolved the United States Agency for International Development, once the world’s largest humanitarian donor. Here’s a quick look at USAID, the impacts of its dissolution an
TOKYO (AP) — Ikebana, the Japanese art of arranging flowers, is a form of expression that dates back more than 500 years. It continues to blossom, quietly, not only with traditionalists but also with newcomers who find its blend of creativity and mindfulness to be restorative. Ikebana can be a bit l
Sept 21 (Reuters) – Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar’s sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of biotech listings in the fall window. While the fall IPO window has gotten off to a rocky start amid unce
Sept 21 (Reuters) – The Pennsylvania Department of Health reported 792 measles cases on Monday, 25 more than on Friday, as the state’s outbreak grew further, remaining at the center of the nation’s worst measles resurgence in decades. Here are some more details: • The state health department confirm
By Christy Santhosh and Padmanabhan Ananthan Sept 21 (Reuters) – The US FDA’s staff reviewers did not raise major concerns about the accuracy and safety of Grail’s blood test designed to detect more than 50 cancers, sending the company’s shares soaring 35% on Monday. The findings on the screening te
Sept 21 (Reuters) – Johnson & Johnson said on Monday its experimental use of Caplyta for bipolar mania met the main goal of a late-stage study, bringing the drug a step closer to expanding beyond its currently approved uses. J&J gained Caplyta through its $14.6 billion acquisition of Intra-Cellular
Sept 21 (Reuters) – Beacon Therapeutics said on Monday its experimental gene therapy improved the ability to read in low-light conditions in a late-stage trial on people with a form of inherited eye disease that can cause progressive vision loss. Here are some details: • The therapy, laru-zova, was
By Manya Saini Sept 21 (Reuters) – Oura kicked off the roadshow for its US initial public offering on Monday, targeting a fully-diluted valuation of $15.62 billion as the smart ring maker tests investor appetite for consumer technology companies after a tepid start to the fall IPO season. The IPO, e
Sept 21 (Reuters) – Novo Nordisk said on Monday its next-generation experimental drug, CagriSema, delivered an estimated average weight loss of 12.4% in a late-stage trial in patients with diabetes, outperforming Eli Lilly’s rival drug. It has been viewed as a successor to Novo’s blockbuster weight-
By Pragyan Kalita Sept 21 (Reuters) – ADARx Pharmaceuticals, which develops RNA-based drugs for rare diseases, said on Monday that it was targeting a valuation of up to $1.74 billion, as it joins a wave of biotech companies planning for a US IPO. Drugmaker AbbVie has agreed to invest up to $100 mill
Sept 21 (Reuters) – Poland’s competition regulator UOKiK said on Monday it fined pharmaceutical wholesaler Neuca 499 million zlotys ($131 million) for participating in a pricing cartel that lasted more than a decade, sending its shares sharply lower. The penalty was the largest in a total 905 millio
By Will Dunham Sept 21 (Reuters) – It is sometimes called “momnesia,” “mommy brain,” “pregnancy brain” or “baby brain” — the forgetfulness, mental fogginess and cognitive changes that many women may experience during pregnancy. For instance, a woman might walk into the kitchen and forget why she did
By Patrick Wingrove LONDON, Sept 21 (Reuters) – Novo Nordisk shares slid as much as 9% on Monday as executives faced tough questions from analysts over the drugmaker’s pricing power and dealmaking strategy ahead of looming patent expiries. Novo aims to launch more than five blockbuster drugs by 2030
VATICAN CITY (AP) — When an ailing Pope John Paul II visited the French shrine at Lourdes in 2004, on his last foreign trip, he delivered a forceful condemnation of abortion and euthanasia as he gasped for air during Mass. Pope Leo XIV is expected to make a similar appeal to protect life when he vis
By Patrick Wingrove LONDON, Sept 21 – Wegovy-maker Novo Nordisk’s CEO Mike Doustdar will face pressure on Monday to set out his strategy for competing with US rival Eli Lilly and how he plans to boost the company’s growth beyond the blockbuster weight-loss drug. Novo rode a wave of demand after laun
Sept 21 (Reuters) – Australia’s Telix Pharmaceuticals said on Monday it has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis, further boosting its radiopharmaceutical ambitions. After adjustments, ITM shareholders are expected
Without Blood Donations, Magen David Adom Could Not Have Saved Tel Aviv Mother’s Life Yael Bibi needed about 50 units of blood and blood components just 10 days after childbirth, revealing why hospitals must have tested donations ready before an emergency By Gabriel Colodro / The Media Line Ten days
Lindsay Clancy ‘s former husband said he forgave her for killing their three young children in his first televised interview Sunday on CBS News’ “60 Minutes” since a jury deadlocked in her trial for the children’s deaths. Patrick Clancy talked about his grief, saying he battled suicidal thoughts aft
